Phenylpropanolamine
& the FDA
Is PPA really harmful?
Is it presently found in over-the-counter products?
"The FDA did not actually issue a mandatory
recall of PPA-containing products, they just asked drug manufacturers
to voluntarily stop selling products containing PPA."
On
6 November 2000, the U.S. Food and Drug Administration issued a warning
that phenylpropanolamine, an ingredient found in many over-the-counter
cold medications and diet aids, may cause strokes and thus should
be avoided. Although the FDA did not issue a mandatory recall of PPA-containing
products, they asked drug manufacturers to voluntarily stop selling
products containing PPA and provide safer alternatives. As a result,
most products that formerly included PPA have now been discontinued
or reformulated without PPA while the FDA proceeds with the regulatory
process necessary to remove all PPA-containing products from the market.
The following list is just an example of OTC cold and dietary aids
that have in the past, contained Phenylpropanolamine:
Dietary Aids:
Acutrim
Dexatrim
Cold, Sinus & Flu Medications:
Alka-Seltzer Cold & Flu Products
Contac Cold Products
Dimetapp Cold & Flu Products
Coricidin D Cold, Flu & Sinus
BC Cold & Sinus Products
Comtrex Flu Therapy & Fever Relief
Naldecon DX Pediatric Drops
Permathene Mega-16
Robitussin CF
Tavist-D 12 Hour Relief of Sinus & Nasal Congestion
Triaminic Products
The product brands listed above and being cited in these circulated
e-mails is now 3-5 years out of date and for the most part, PPA has
been removed from those products. Since the FDA never actually
issued a formal mandate banning the use of PPA, nor requiring manufacturers
to halt the use of PPA in OTC drugs, it is suggested that consumers
should check existing OTC medications in their medicine cabinets,
as well as continue to check product ingredients before purchasing
current OTC dietary aids & cold medications.
The FDA has noted:
"There is no comprehensive, updated list available from the
FDA. The FDA is aware of emails circulating widely that list many
products allegedly containing PPA. Those emails are no longer valid
and should be ignored. Please read the labels of OTC products to determine
if they contain PPA."
The FDA continues to answer PPA questions toll-free at (888) INFO-FDA.
A direct line, although it is not toll-free, is (301) 827-4570. The
FDA also has a Phenylpropanolamine
(PPA) Information Page available on their web site. The FDA has
advised that consumers go through their medicine cabinets, paying
special attention to cold remedies and diet aids, and discard any
medications that list phenylpropanolamine as one of their ingredients.
According to the FDA, "Although the risk of hemorrhagic stroke is
very low, FDA recommends that consumers not use any products that
contain PPA." The FDA warning came as a result of a May 2000 study
conducted at Yale University School of Medicine, in which the Hemorrhagic
Stroke Project found PPA to increase the risk of hemorrhagic stroke,
a type of stroke characterized by bleeding in the brain. In October
2000, an FDA advisory committee confirmed the findings in the Yale
study published by The New England Journal of Medicine, which suggested
that PPA could raise the risk of stroke even in young people aged
18 to 49.
Not everyone is convinced that PPA poses nearly as much of a threat
to consumers as claimed, and some critics have maintained the withdrawal
was initiated by an overly cautious FDA based on flawed studies.
Return
to Info-Library